At a glance
ClinicalIndex Comparison RecordN/ACompleted· 218 enrolled
Drug / intervention
Intracranial thrombectomy stentdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Multicenter, Randomized Controlled, Non-inferiority Study to Investigate the Effectiveness and Safety of Intracranial Embolization Stents for Endovascular Treatment of Acute Ischemic Stroke
In Brief
A clinical study evaluating Intracranial thrombectomy stent for Ischemic Stroke, Acute and 2 related conditions. Completed, enrolled 218 participants across 14 sites.
Detailed Summary
A prospective, multicenter, randomized controlled, non-inferiority study to investigate the effectiveness and safety of SINOMED SR for endovascular treatment of acute ischemic stroke
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesChina
CollaboratorsThe General Hospital of Eastern Theater Command
Timeline
N/ACompletedFinished
20222023202420252026
First PostedJul 2021
Enrollment StartAug 2021
Primary CompletionApr 2022
Study CompletionJun 2022
TodayJul 2026
First PostedJul 22, 2021
Enrollment StartAug 8, 2021
Primary CompletionApr 7, 2022
Study CompletionJun 24, 2022
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 4.9 years ago
Interventions
Intracranial thrombectomy stentdevice
Intracranial thrombectomy stents for ischemic stroke patients within 24 hours of symptom onset